SCHEMBL1244307

SCHEMBL1244307

NCCC[C@H](N)C(=O)N[C@@H](CCc1ccc(F)cc1)C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.47
HDAC4 P56524 6/20 0.47
TRPV1 Q8NER1 6/20 0.46
HDAC3 O15379 5/20 0.46
HDAC7 Q8WUI4 5/20 0.46
HDAC2 Q92769 5/20 0.46
HDAC10 Q969S8 5/20 0.46
HDAC11 Q96DB2 5/20 0.46
HDAC8 Q9BY41 5/20 0.46
HDAC6 Q9UBN7 5/20 0.46
HDAC9 Q9UKV0 5/20 0.46
HDAC5 Q9UQL6 5/20 0.46
BDKRB2 P30411 1/20 0.42
ACP1 P24666 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
SCN9A Q15858 1/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245477 1.00 HDAC1 (0.47) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1246389 0.94 HDAC1 (0.49) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1244303 0.94 HDAC1 (0.49) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1246051 0.94 HDAC1 (0.49) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1245469 0.94 HDAC1 (0.49) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1244196 0.92 BDKRB2 (0.48) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1246469 0.91 MCHR1 (0.47) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1245391 0.91 HDAC1 (0.50) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1244199 0.90 LTA4H (0.41) HDAC1HDAC4TRPV1HDAC3HDAC7
SCHEMBL1245392 0.90 ACP1 (0.49) HDAC1HDAC4TRPV1HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893020-B2 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide MPEX PHARMACEUTICALS, INC. (US) 2011-02-22 US disclosed
US-7879795-B2 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide MPEX PHARMACEUTICALS, INC. (US) 2011-02-01 US disclosed